These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6747669)

  • 1. Treatment of canine transmissible venereal tumor by intravenous administration of protein A.
    Cohen D; Fer MF; Pearson JW; Herberman RB
    J Biol Response Mod; 1984; 3(3):271-7. PubMed ID: 6747669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumor.
    Zander AR; Sarpell S; Cunningham B; Hess AD; Johnston DA; Epstein RB
    Exp Hematol; 1980 Oct; 8(9):1123-8. PubMed ID: 6164563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
    Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
    J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow infusion following high dose chemotherapy of the canine transmissible venereal tumor (TVT).
    Epstein RB; Sarpel SC
    Exp Hematol; 1980 Jul; 8(6):683-9. PubMed ID: 7009184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 125IUdR technique for measuring the cell loss from subcutaneously growing canine transmissible venereal tumours.
    Holmes JM
    Res Vet Sci; 1981 Nov; 31(3):306-11. PubMed ID: 7342225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine transmissible venereal tumor (TVT): a review.
    Vermooten MI
    J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A.
    Terman DS
    Fed Proc; 1981 Jan; 40(1):45-9. PubMed ID: 7450063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of canine transmissible venereal sarcoma.
    Yang TJ
    J Am Vet Med Assoc; 1987 Jul; 191(1):6. PubMed ID: 3610780
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC; Valladão ML; Metze K
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of transmissible venereal tumors in dogs with intratumoral interleukin-2 (IL-2). A pilot study.
    Den Otter W; Hack M; Jacobs JJ; Tan JF; Rozendaal L; Van Moorselaar RJ
    Anticancer Res; 2015 Feb; 35(2):713-7. PubMed ID: 25667450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.
    Gordon BR; Matus RE; Saal SD; MacEwen EG; Hurvitz AI; Stenzel KH; Rubin AL
    J Natl Cancer Inst; 1983 Jun; 70(6):1127-33. PubMed ID: 6343694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semen quality during vincristine treatment in dogs with transmissible venereal tumor.
    Saratsis P; Ypsilantis P; Tselkas K
    Theriogenology; 2000 Mar; 53(5):1185-92. PubMed ID: 10798495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
    Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
    J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
    Brown NO; Calvert C; MacEwen EG
    J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of C-bands in canine transmissible venereal tumor cells.
    Richardson VB; Sapp WJ; Adams EW
    Cornell Vet; 1987 Apr; 77(2):161-7. PubMed ID: 3568686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of canine mammary carcinoma after immunoadsorption therapy.
    Holohan TV; Phillips TM; Bowles C; Deisseroth A
    Cancer Res; 1982 Sep; 42(9):3663-8. PubMed ID: 7049360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.